AQUABOUNTY TECHNOLOGIES (AQB) Fundamental Analysis & Valuation

NASDAQ:AQB • US03842K3095

Current stock price

0.9699 USD
0 (0%)
Last:

This AQB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. AQB Profitability Analysis

1.1 Basic Checks

  • AQB had negative earnings in the past year.
  • In the past year AQB has reported a negative cash flow from operations.
  • AQB had negative earnings in each of the past 5 years.
  • AQB had a negative operating cash flow in each of the past 5 years.
AQB Yearly Net Income VS EBIT VS OCF VS FCFAQB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M

1.2 Ratios

  • AQB's Return On Assets of -178.76% is on the low side compared to the rest of the industry. AQB is outperformed by 86.43% of its industry peers.
Industry RankSector Rank
ROA -178.76%
ROE N/A
ROIC N/A
ROA(3y)-154.24%
ROA(5y)-97.11%
ROE(3y)-323.04%
ROE(5y)-198.77%
ROIC(3y)N/A
ROIC(5y)N/A
AQB Yearly ROA, ROE, ROICAQB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for AQB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AQB Yearly Profit, Operating, Gross MarginsAQB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. AQB Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for AQB has been increased compared to 1 year ago.
  • The number of shares outstanding for AQB has been reduced compared to 5 years ago.
  • Compared to 1 year ago, AQB has a worse debt to assets ratio.
AQB Yearly Shares OutstandingAQB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AQB Yearly Total Debt VS Total AssetsAQB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -53.41, we must say that AQB is in the distress zone and has some risk of bankruptcy.
  • AQB's Altman-Z score of -53.41 is on the low side compared to the rest of the industry. AQB is outperformed by 92.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -53.41
ROIC/WACCN/A
WACCN/A
AQB Yearly LT Debt VS Equity VS FCFAQB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • AQB has a Current Ratio of 1.18. This is a normal value and indicates that AQB is financially healthy and should not expect problems in meeting its short term obligations.
  • AQB's Current ratio of 1.18 is on the low side compared to the rest of the industry. AQB is outperformed by 85.27% of its industry peers.
  • A Quick Ratio of 1.18 indicates that AQB should not have too much problems paying its short term obligations.
  • AQB has a Quick ratio of 1.18. This is amonst the worse of the industry: AQB underperforms 84.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
AQB Yearly Current Assets VS Current LiabilitesAQB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. AQB Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 87.67% over the past year.
  • Looking at the last year, AQB shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)87.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.23%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 12.23% on average over the next years. This is quite good.
  • AQB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 74.02% yearly.
EPS Next Y86.82%
EPS Next 2Y25.67%
EPS Next 3Y16.68%
EPS Next 5Y12.23%
Revenue Next Year43.65%
Revenue Next 2Y-25.67%
Revenue Next 3Y40.31%
Revenue Next 5Y74.02%

3.3 Evolution

AQB Yearly Revenue VS EstimatesAQB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2M 4M 6M 8M
AQB Yearly EPS VS EstimatesAQB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. AQB Valuation Analysis

4.1 Price/Earnings Ratio

  • AQB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AQB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AQB Price Earnings VS Forward Price EarningsAQB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AQB Per share dataAQB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -2 -4 -6

4.3 Compensation for Growth

  • AQB's earnings are expected to grow with 16.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.67%
EPS Next 3Y16.68%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AQB Dividend Analysis

5.1 Amount

  • AQB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AQB Fundamentals: All Metrics, Ratios and Statistics

AQUABOUNTY TECHNOLOGIES

NASDAQ:AQB (4/23/2026, 11:01:23 AM)

0.9699

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-31
Earnings (Next)05-13
Inst Owners9.94%
Inst Owner Change0%
Ins Owners1.04%
Ins Owner Change0%
Market Cap4.99M
Revenue(TTM)N/A
Net Income(TTM)-18.49M
Analysts45
Price TargetN/A
Short Float %1.53%
Short Ratio2.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)0
Avg Revenue beat(4)-100%
Min Revenue beat(4)-100%
Max Revenue beat(4)-100%
Revenue beat(8)1
Avg Revenue beat(8)-58.13%
Revenue beat(12)3
Avg Revenue beat(12)-38.9%
Revenue beat(16)4
Avg Revenue beat(16)-32.45%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.76
EYN/A
EPS(NY)-7.35
Fwd EYN/A
FCF(TTM)-3.26
FCFYN/A
OCF(TTM)-2.69
OCFYN/A
SpS0
BVpS-0.37
TBVpS-0.37
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -178.76%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-154.24%
ROA(5y)-97.11%
ROE(3y)-323.04%
ROE(5y)-198.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 324.07%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z -53.41
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2285.55%
Cap/Depr(5y)1493.12%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.23%
EPS Next Y86.82%
EPS Next 2Y25.67%
EPS Next 3Y16.68%
EPS Next 5Y12.23%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year43.65%
Revenue Next 2Y-25.67%
Revenue Next 3Y40.31%
Revenue Next 5Y74.02%
EBIT growth 1Y17.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.59%
EBIT Next 3Y32.51%
EBIT Next 5Y22.74%
FCF growth 1Y81.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.8%
OCF growth 3YN/A
OCF growth 5YN/A

AQUABOUNTY TECHNOLOGIES / AQB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AQUABOUNTY TECHNOLOGIES?

ChartMill assigns a fundamental rating of 1 / 10 to AQB.


What is the valuation status of AQUABOUNTY TECHNOLOGIES (AQB) stock?

ChartMill assigns a valuation rating of 0 / 10 to AQUABOUNTY TECHNOLOGIES (AQB). This can be considered as Overvalued.


How profitable is AQUABOUNTY TECHNOLOGIES (AQB) stock?

AQUABOUNTY TECHNOLOGIES (AQB) has a profitability rating of 0 / 10.